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A B S T R A C T
Multiple sclerosis (MS) is an inflammatory disease of unknown etiology involving the central nervous system. Cer-
tain clinical manifestations affect the oro-facial region. Three in particular should be of interest to the dentist: tri-
geminal neuralgia, sensory neuropathy of the trigeminal nerve and facial palsy. The aim of this study was to determine
the oral health status, the frequency of subjective symptoms and temporomandibular disorders (TMD) subtype accord-
ing to Research diagnostic criteria for temporomandibular disorders (RDC/TMD) among MS patients. Examinees in
this study were 50 patients suffering from MS, who were at least once treated during their disease in the Clinic Hospi-
tal Center, Rijeka, Clinic for Neurology. All examinees had to meet the diagnostic criteria for clinically and laboratory
confirmed MS, according to Poser. The results show the difference in mean DMFT (decayed, missing, filled teeth) be-
tween MS and the control group. The number of decayed and missing teeth was higher, but the number of filled teeth
was significantly lower in MS group. Eighty-two per cent of the subjects with MS had a least one symptom of dysfunc-
tion compared with 24% of the subjects in the healthy control group. In the present study, pain, the pain during mouth
opening, the difficulty with mouth opening and temporomandibular joint (TMJ) sounds were more commonly reported
in the MS group than in the control group. This study shows a statistically significant excess of dental caries and
temporomandibular disorders among MS patients compared with the control group. These results suggest that MS is a
possible etiological factor in temporomandibular disorders.
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Introduction
Multiple sclerosis (MS) is an inflammatory disease of
unknown etiology involving the central nervous sys-
tem1. It is characterized by either a relapsing-remitting
or progressive course and a pathologic triad of inflam-
mation, demyelination, and gliosis (scarring). MS is a
chronic, frequently progressive disease that predomi-
nantly attacks the myelin sheath of the central nervous
system (CNS – brain and spinal cord). Demyelination
occurs, often with scarring at multiple sites throughout
the CNS. It is hypothesized that an external »trigger«
such as a virus may precipitate an autoimmune re-
sponse in genetically susceptible individuals2–5. Lesions
of MS are traditionally said to be disseminated in time
and space. Manifestations of MS vary from a benign ill-
ness to a rapidly evolving and incapacitating disease re-
quiring profound adjustments in life-style and goals for
patients and their families. Complications from MS af-
fect multiple body systems; hence, a multidisciplinary
approach is recommended to optimize the clinical care.
Symptoms vary widely, but most commonly include: gait
disturbances, sensory complaints (numbness, paresthe-
sias, burning, feelings of constriction or pain), visual
problems, fatigue, incoordination, bladder, bowel and
sexual dysfunction, and partial or complete paralysis in
severe cases6–9. Mild cognitive impairment occurs in
many patients with MS, while a smaller proportion
(about 10%) experience serious intellectual deteriora-
tion. The cause and cure are unknown, although symp-
tomatic management is possible and certain immuno-
regulatory agents reduce the relapse rate and may
prove to slow the disease progression. Since MS affects
the whole body, orofacial aspects of the disease must be
expected, particularly since loss of muscular coordina-
tion may result in a diminished ability to maintain oral
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hygiene10,11. Certain clinical manifestations affect the
oro-facial region. Three in particular should be of inter-
est to the dentist: trigeminal neuralgia (tic douloureux),
sensory neuropathy of the trigeminal nerve (parasthe-
sia) and facial palsy12–14. Trigeminal neuralgia usually
appears after the diagnosis of multiple sclerosis has
been made and is present in about 1.9% of cases. It is,
however, the first manifestation of the disease in 0.3% of
cases15.
The aim of this study was to determine the oral health
status, the frequency of subjective symptoms and TMD
subtype according to RDC/TMD among MS patients.
Subjects and Methods
Examinees in this study were 50 patients suffering
from MS, who were treated during their disease for at
least once in the University Hospital Center, Rijeka,
Clinic for Neurology.
The examined group consisted of 37 male patients
and 13 female patients, aged 20 to 60. All examinees
had to meet diagnostic criteria for clinically and labora-
tory confirmed MS, according to Poser16. The control
group was formed by individual matching method, which
comprises one healthy individual per one patient of the
same age and sex. All subjects submitted informed con-
sent before participation.
The data were collected in two parts. The anamnestic
examination was carried out prior to the clinical exami-
nation, and the examiner of the clinical examination was
unaware of the results of the anamnestic examination.
Oral examination was performed in accordance with
WHO diagnostic criteria to determine the number of de-
cayed, missing, filled teeth (DMF), as well as the num-
ber of remaining teeth17.
The clinical examination of the stomatognathic sys-
tem included the determination of the range of mandib-
ular movements, the assessment of TMJ function, the
recording of pain during movements and during palpa-
tion of TMJ and masticatory muscles. All examinations
were performed according to the RDC/TMD18.
The history questionnaire/examination forms were
implemented as electronic forms and input directly into
computers using the program »GnatoBaza 1.2.« (School
of Medicine, University of Rijeka). The program is writ-
ten in Microsoft Visual Basic and Microsoft Access (Mi-
crosoft Corp, Redmond, Wash.). It consists of 4 main
parts (anamnestic questionnaire, clinical card, data base
and part for processing and forwarding data for statisti-
cal analysis) which facilitate the saving and analyzing
of the obtained data.
Statistical analysis was performed using SPSS 12.0.
Statistical package (SPSS Inc., Chicago, IL, USA). Stu-
dent’s t-test for independent samples was applied to test
the significance of the difference between arithmetic
means of certain parameters. For the variables whose
values are expressed in categories the testing of the sig-
nificance of the difference between groups was carried
out by chi-square test.
Results
Table 1. shows the number of DMF teeth in MS and
control group. No significant difference was observed in
the number of decayed teeth between the two groups
(p=0.63), but significantly more teeth were missing in
the MS group (p=0.001), and DMF teeth were signifi-
cantly more numerous in the MS group. The control
group had significantly more filled teeth than MS group
(p=0.004)
Table 2. shows the symptoms of TMJ disorders am-
ong MS and the control group. No difference was ob-
served in TMJ sounds. Pain, the pain during mouth
opening and difficulty with mouth opening were signifi-
cantly more frequent in MS group.
Table 3. shows TMD diagnoses according to RDC/TMD
criteria. MS group showed a much higher prevalence of
all three groups RDC/TMD diagnoses. The highest dif-
ference between the two groups was in group I (myo-
fascial pain) TMDs (p=0.001).
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TABLE 1
DECAYED, MISSING, FILLED TEETH AND DMFT INDEX IN
MULTIPLE SCLEROSIS AND CONTROL GROUP
Dental status
MS group Control group
t p
X SD X SD
Decayed teeth 1.24 2.10 0.54 1.58 1.88 0.63
Missing teeth 7.04 3.89 3.94 2.74 4.61 0.001
Filled teeth 4.30 4.69 7.24 5.36 2.92 0.004
DMFT Index 12.58 6.32 11.72 5.75 0.72 0.478
MS –multiple sclerosis, DMFT – decayed, missing, filled teeth
TABLE 2
SUBJECTIVE SYMPTOMS OF TEMPOROMANDIBULAR DISORDERS IN MULTIPLE SCLEROSIS AND CONTROL GROUP
TMD symptoms
MS group Control group

2 p
N % N %
Pain 27 54 5 10 2.22 0.001
Pain in front of the ear 6 12 1 2 3.84 0.05
Pain during mouth opening 5 10 1 2 2.84 0.092
Difficulty with mouth opening 11 22 0 0 12.36 0.001
TMJ sounds 15 30 5 10 6.25 0.12
TMD – temporomandibular disorders, TMJ – temporomandibular joint, MS – multiple sclerosis
Discussion
In this study oral health status, signs, symptoms and
type of temporomandibular disorder were analyzed in
50 multiple sclerosis patients and 50 controls without
multiple sclerosis who were the same age and sex.
There was a difference in mean DMFT between MS and
the control group. The number of decayed and missing
teeth was higher, but the number of filled teeth was sig-
nificantly lower in MS group. Symons et al. report no
differences in the number of decayed, missing and filled
teeth between MS patients and controls, but this pre-
liminary study was carried out on only 22 MS pati-
ents11. Considering that the number of DMFT index of
the control group corresponds with the research results
of other studies, our results may suggest poor oral
health among MS patients19–21.
Eighty-two per cent of the subjects withMS had a least
one symptom of dysfunction compared with 24% of the
subjects in the healthy control group. In the present study,
pain, the pain during mouth opening, the difficulty with
mouth opening and TMJ sounds were more commonly re-
ported in the MS group than in the control group.
TMJ sounds were found in 30% of the MS group and
10% of the control group. The values obtained agree
with the data from literature in which sounds in the
TMJ are present in 11–36%22–25.
In Mercadoÿs studies click was present in 29.16 %
males and 30.72% females26. Dworkin established a dif-
ference between the appearance of sound in persons
with and without TMD symptoms. In clinical examina-
tion the click was noticed in 43% examinees with TMD
and 24% in control group27.
Doubt has been cast on the relevance of TMJ clicking
for the TMD diagnostic criteria, and the presence of
sounds to joint pathology remains uncertain28–30. Due to
these considerations, the clicking of the TMJs was not
taken into account when classifying the subgroups of
TMD in the clinical part of the study.
In the MS group facial pain was reported by 54% and
TMJ pain (pain in front of the ear or during jawmovement)
by 22% compared to the control group in which facial
pain was reported by 10%, and TMJ pain 4% examinees.
Salonen et al. found that TMJ pain during mandibular
movement was reported by 7%, and head and/or facial
pain by 11% subjects in the age group 30–39 years28.
These results are also close to the results of Von Korff et
al31. Frequent or occasional pain in the jaws or face dur-
ing chewing has been reported by as many as 44% of
35-year-old subjects32.
High prevalence of pain in MS group is in agreement
with other studies that reported that pain is more prev-
alent among MS patients. Warnell found that 233 (64%)
of the 364 patients with MS in his descriptive study had
experienced pain at some time during their disease, and
40% of those patients reported that they were never
pain-free33. Forty-nine percent of examinees with pain
experienced difficulty in working, and 44% had diffi-
culty in sleeping because of the pain. Stenager came to
similar conclusions: only 35% of patients with MS in
their study were pain-free34.
Muscle disorders and disc displacement with reduc-
tion were the most common TMD findings in MS group.
The finding that over half of the patients belonged to the
myogenous group is in agreement with the results of
List and Dworkin who reported that approximately 76%
of patients with TMD had a muscular disorder35. Ran-
tala found similar results in nonpatient Finnish popu-
lation36. Others found approximately equal proportions
of myogenous vs. arthrogenous subgroups in patient
and population-based samples37,38.
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TABLE 3
RESEARCH DIAGNOSTIC CRITERIA FOR TEMPOROMANDIBULAR DISORDERS DIAGNOSES
IN MULTIPLE SCLEROSIS AND CONTROL GROUP
RDC/TMD diagnoses
MS group Control group

2 p
N % N %
Group I diagnoses
Myofascial pain 16 32 0 0
19.05 0.001Myofascial pain with limited opening 0 0 0 0
Number in Group I 34 68 50 100
Group II diagnoses
DD with reduction 6 12 2 4 2.17 0.14
DD without reduction, with limited opening 0 0 0 0
DD without reduction, without limited opening 0 0 0 0
Number in Group II 44 88 48 96
Group III diagnoses
Arthralgia 6 12 0 0 7.52 0.23
Osteoarthritis 0 0 0 0
Osteoarthrosis 1 2 0 0
Number in Group III 43 86 50 100
RDC/TMD – research diagnostic criteria for temporomandibular disorders, MS – multiple sclerosis, DD – disc displacement
Conclusion
This study shows a statistically significant excess of
dental caries and temporomandibular disorders among
MS patients compared with the control group. These re-
sults suggest that MS is a possible etiological factor of
temporomandibular disorders.
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ORALNO ZDRAVLJE I TEMPOROMANDIBULARNA DISFUNKCIJA U BOLESNIKA S MULTIPLOM
SKLEROZOM
S A @ E T A K
Multipla skleroza (MS) je upalna bolest nepoznate etiologije koja zahva}a sredi{nji `iv~ani sustav. Odre|ene
klini~ke manifestacije zahva}aju i orofacijalnu regiju od kojih su tri posebno interesantne stomatologu. To su neu-
ralgija n. trigeminusa, senzorna neuropatija istog te pareza n. facialisa. Cilj istra`ivanja bilo je odrediti oralni status,
u~estalost subjektivnih simptoma te vrstu disfunkcije prema RDC/TMD (research diagnostic criteria for temporo-
mandibular disorders) protokolu u MS bolesnika. Ispitivana skupina sastojala se od 50 MS bolesnika koji su barem
jednom tijekom svoje bolesti bili lije~eni u Klini~ko bolni~kom centru Rijeka, Klinici za neurologiju. Svi ispitanici
morali su imati klini~ko i laboratorijski potvr|enu multiplu sklerozu, prema Poseru. Rezultati pokazuju statisti~ki
zna~ajnu razliku DMFT (decayed, missing, filled teeth) indeksa izme|u MS bolesnika i kontrolne skupine. Broj kari-
oznih i ekstrahiranih zubi bio je ve}i, no broj zubi opskrbljenih ispunima zna~ajno manji nego u kontrolne skupine. 82
% ispitanika s MS-om imalo je barem jedan simptom disfunkcije za razliku od 24 % ispitanika kontrolne skupine. Bol,
bol pri otvaranju usta, ote`ano otvaranje usta i zvukovi u temporomandibularnog zgloba u~estaliji su u MS bolesnika
nego u kontrolnoj skupini. Ova studija pokazuje statisti~ki zna~ajnu prevalenciju karijesa i temporomandibularne
disfunkcije me|u pacijentima s MS-om nego kod kontrolne skupine. Ovakvi rezultati potvr|uju da je MS mogu}i
etiolo{ki faktor temporomandibularnih disfunkcija.
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